Anlon Healthcare Ltd
NSE: AHCL | BSE: 544497
₹15.91
₹0.31
(1.99%)
As on 28-Aug-2026IST
Market cap
₹846 Cr
Revenue (TTM)
₹174 Cr
P/E Ratio
29.1
P/B Ratio
3.2
Div. Yield
0 %
Quality Score
1/10
Growth Score
5/10
Valuation Score
5/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹29 Cr
-
ROE
18.7 %
-
ROCE
22 %
-
Industry P/E
55.07
-
EV/EBITDA
18.6
-
Debt to Equity
0.2
-
Book Value
₹5
-
EPS
₹3
-
Face value
2
-
Shares outstanding
531,515,000
5 Years Aggregate
CFO
₹-109.82 Cr
EBITDA
₹113.53 Cr
Net Profit
₹64.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anlon Healthcare
| 5.4 | 1.0 | 11.6 | 74.8 | -- | -- | -- |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anlon Healthcare
|
15.9 | 846.2 | 174.2 | 29.1 | 26.3 | 13.7 | 29.1 | 3.2 |
| 1,350.2 | 16,589.5 | 2,590.4 | 603.0 | 29.3 | 19.6 | 27.5 | 4.8 | |
| 577.7 | 10,912.7 | 885.7 | 234.9 | 27.8 | 18 | 46.5 | 4.9 | |
| 1,481.1 | 15,506.7 | 1,108.4 | 270.2 | 28.3 | 14.5 | 56.3 | 7.5 | |
| 1,869.4 | 35,497.5 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 35.1 | 6.8 | |
| 23,205.0 | 29,798.0 | 2,371.8 | 497.8 | 28.0 | 28.5 | 59.9 | 14.7 | |
| 975.6 | 5,827.4 | 942.6 | 9.9 | 0.3 | 1.2 | 672.4 | 4.5 | |
| 1,482.1 | 6,826.8 | 691.7 | 130.8 | 24.5 | 14.5 | 54 | 7.1 | |
| 1,152.1 | 13,020.2 | 675.6 | 183.6 | 32.2 | 22.7 | 71.3 | 14.1 | |
| 365.0 | 10,310.7 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 18.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Anlon Healthcare
Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API... products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India. Read more
-
Incorporated
2013
-
Chairman
Punitkumar R Rasadia
-
Managing Director
Punitkumar R Rasadia
-
Headquarters
Rajkot, Gujarat
-
Website
Looking for more details about Anlon Healthcare Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Anlon Healthcare
What is the current share price of Anlon Healthcare Ltd Today?
The share price of Anlon Healthcare Ltd is ₹15.91 (NSE) and ₹15.92 (BSE) as of 28-Aug-2026 IST. Anlon Healthcare Ltd has given a return of 74.84% in the last 1 years.
What is the current PB & PE ratio of Anlon Healthcare Ltd?
The P/E ratio of Anlon Healthcare Ltd is 29.12 times as on 28-Aug-2026, a 47 discount to its peers’ median range of 55.07 times.
The P/B ratio of Anlon Healthcare Ltd is 3.16 times as on 28-Aug-2026, a 29 discount to its peers’ median range of 4.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
2.07 |
2.57 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Anlon Healthcare Ltd?
The 52-week high and low of Anlon Healthcare Ltd are Rs 17.28 and Rs 9.08 as of 30-Aug-2026.
What is the market cap of Anlon Healthcare Ltd?
Anlon Healthcare Ltd has a market capitalisation of ₹ 846 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Anlon Healthcare Ltd?
Before investing in Anlon Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.